Abstract:Experimentalallergic encephalomyelitis(EAE) is an animal model for inflammatory demyelinating autoimmune disease, i.e., multiple sclerosis (MS). In the present study, we investigated the antineuroinflammatory/neuroprotective effects of C16, an alpha upsilon beta 3 integrin-binding peptide, and recombinant rat ciliary neurotrophic factor (CNTF), a cytokine that was originally identified as a survival factor for neurons, in an acute rodent EAE model. In this model, C16 peptide was injected intravenously every day for 2 weeks, and CNTF was delivered into the cerebral ventricles with Alzet miniosmotic pumps. Disease severity was assessed weekly using a scale ranging from 0 to 5. Multiple histological and molecular biological assays were employed to assess inflammation, axonal loss, neuronal apoptosis, white matter demyelination, and gliosis in the brain and spinal cord of different groups. Our results showed that the EAE induced rats revealed a significant increase in inflammatory cells infiltration, while C16 treatment could inhibit the infiltration of leukocytes and macrophages down to 2/3-1/3 of vehicle treated EAE control (P < 0.05). The delayed onset of disease, reduced clinical score (P < 0.01) in peak stage and more rapid recovery also were achieved in C16 treated group. Besides impairing inflammation, CNTF treatment also exerted direct neuroprotective effects, decreasing demyelination and axon loss score (P < 0.05 versus vehicle treated EAE control), and reducing the neuronal death from 40 to 50% to 10 to 20% (P < 0.05). Both treatments suppressed the expression of cytokine tumor necrosis factor-alpha and interferon-gamma when compared with the vehicle control (P < 0.05). Combined treatment with C16 and CNTF produced more obvious functional recovery and neuroprotective effects than individually treatment (P < 0.05). These results suggested that combination treatment with C16 and CNTF, which target different neuroprotection pathways, may be an effective therapeutic alternative to traditional therapy.

Construction and Preliminary Investigation of a Plasmid Containing a Novel Immunotoxin DT390-IL-18 Gene for the Prevention of Murine Experimental Autoimmune Encephalomyelitis.

In vivo administration of plasmid DNA encoding recombinant immunotoxin DT390-IP-10 attenuates experimental autoimmune encephalomyelitis.

[An Expression Plasmid Encoding Recombinant Immunotoxin IP10-DT390 Suppresses the Experimental Autoimmune Encephalomyelitis].

Prevention of murine experimental autoimmune encephalomyelitis by in vivo expression of a novel recombinant immunotoxin DT390-RANTES

Gene Therapy of Experimental Autoimmune Thyroiditis Mice by in Vivo Administration of Plasmid Dna Coding for Human Interleukin-10

Development of an improved animal model of experimental autoimmune myositis.

Experimental Studies on the Therapy of EAE with DT390-IL2 Recombinant Plasmid

[The Research on Construction and Expression of Eukaryotic Expression Plasmid for a Recombinant Immunotoxin Mmip-1Alpha-dt390].

[Study of the Construction and Function of an Eukaryotic Expression Plasmid of Immunotoxin DT390 Gene].

[Construction and Prokaryotic Expression of a Recombinant Immunotoxin Fused with Mouse Interleukin 18 and Truncated Pseudomonas Exotoxin].

The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-induced Hepatitis in Mice.

[Effects of Intrasplenic Transplantation of IL-18 Gene-Modified Fetal Hepatocytes on Mouse Immune Function]

[Construction and Functional Analysis of a Novel Eukaryotic Expression Plasmid of Recombinant Immunotoxin DT390-Rantes].

Antineuroinflammatory and neurotrophic effects of CNTF and C16 peptide in an acute experimental autoimmune encephalomyelitis rat model.

Construction of Eukaryotic Expression Vector Containing Mouse IL-18 and Examination of the Bioactivity of the Expressed IL-18

Effect of intravenous injecting plasmid encoding interleukin-19-IgG on ex-perimental autoimmune myocarditis in rats

Effect of hydrodynamics-based delivery of IL-18BP fusion gene on rat experimental autoimmune myocarditis.

Construction of Recombinant Eukaryotic Expressing Plasmid of Mouse IL-18 and Analysis of Its Gene Polymorphism

A Novel Human Truncated IL12rβ1-Fc Fusion Protein Ameliorates Experimental Autoimmune Encephalomyelitis Via Specific Binding of P40 to Inhibit Th1 and Th17 Cell Differentiation

Study on MCI-186 Treatment in Experimental Autoimmune Encephalomyelitis

Prevention of Experimental Autoimmune Myocarditis by Hydrodynamics-Based Naked Plasmid DNA Encoding CTLA4-Ig Gene Delivery